Literature DB >> 15527689

Pharmacogenetic study of statin therapy in cholesterol reduction.

Theodore A Kotchen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15527689     DOI： 10.1007/s11906-004-0039-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  5 in total

1.  Using pharmacogenetics to improve drug safety and efficacy.

Authors:  Susanne B Haga; Wylie Burke
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

Review 2.  Geneticism of essential hypertension.

Authors:  Friedrich C Luft
Journal:  Hypertension       Date:  2004-04-26       Impact factor: 10.190

Review 3.  Genetic predisposition to salt-sensitivity: a systematic review.

Authors:  Esther Beeks; Alfons G H Kessels; Abraham A Kroon; Melanie M van der Klauw; Peter W de Leeuw
Journal:  J Hypertens       Date:  2004-07       Impact factor: 4.844

4.  C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic.

Authors:  S T Turner; G L Schwartz; A B Chapman; E Boerwinkle
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

5.  Genetically defined risk of salt sensitivity in an intercross of Brown Norway and Dahl S rats.

Authors:  A W Cowley; M Stoll; A S Greene; M L Kaldunski; R J Roman; P J Tonellato; N J Schork; P Dumas; H J Jacob
Journal:  Physiol Genomics       Date:  2000-04-27       Impact factor: 3.107
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.